Navigation Links
Some Breast Cancers May Regress on Their Own
Date:11/25/2008

Study of women receiving mammography suggests it happens

TUESDAY, Nov. 25 (HealthDay News) - Some breast cancers may naturally disappear without treatment, a study of women undergoing mammography suggests.

The Norwegian study found that more cases of breast cancer were diagnosed after a regular screening program was put in place than before. That has led specialists to suspect that some of the diagnosed tumors would have spontaneously regressed had they not been detected and treated as the result of more rigorous mammography guidelines.

But since doctors can't yet determine which tumors might regress and which might go on to be dangerous, the finding isn't likely to change recommendations for mammography, experts said.

"The problem is, we don't know the natural history [of breast cancer]," said Dr. Jay Brooks, chairman of hematology/oncology at Ochsner Health System in Baton Rouge, La. "I am sure there are some that do regress. The problem is, we can't pick up those that are going to regress. It's one of the unanswerable questions."

The study was published in the Nov. 24 issue of the Archives of Internal Medicine.

Cancer experts have long suspected that some cancers may grow and then, for reasons that are unclear, simply shrink again and disappear. The new breast cancer trial appears to support that notion.

The study took advantage of the fact that new biennial (once every two years) screening mammography programs were instituted throughout Europe in the 1990s. Such a program began in Norway in 1996.

Researchers from the Norwegian Institute of Public Health tracked the incidence of breast cancer among more than 119,000 women aged 50 to 64 who participated in three rounds of biennial mammography screening between 1996 and 2001.

They then compared that data to the rates of breast cancer for almost 110,000 women of similar age between 1992 and 1997, largely before the new guidelines came into effect. When Norway began offering mammograms in 1996, almost all these women went and got a one-time screen.

Although it might be expected that the two groups of women would have breast cancer at similar rates, they did not. In fact, the women in the later cohort -- who got mammograms once every 2 years -- had a 22 percent higher rate of tumors than the women in the earlier, less heavily screened group.

According to the authors, changes in hormone therapy use over the study period did not explain the difference. So why would more frequent screening mean more cancers?

What probably happened, the authors theorized, is that some of the tumors detected during more frequent screening would not otherwise have caused women trouble if they had remained undetected. These tumors might have either remained stable or, more likely, spontaneously regressed.

In fact, there have been 32 cases of spontaneous regression of breast cancer reported in one recent review of the medical literature. And not all actual cases of spontaneous regression end up being documented.

In addition, autopsy studies have revealed that many women die without ever knowing they had a breast cancer.

One expert was intrigued by the findings.

"The study is very provocative and it generates an interesting hypothesis: that it's possible some screen-detected breast cancers would not ever lead to death from breast cancer and are unnecessarily diagnosed and treated," said Dr. Jeanne Mandelblatt, associate director for population sciences at Georgetown University's Lombardi Comprehensive Cancer Center in Washington, D.C.

"But this study design can't prove or disprove that hypothesis," she added. "This study is inconclusive because these women were not randomized; there's no data about the tumor sizes or tumor characteristics in the two groups, and no data about the breast cancer death rate in the two groups."

Still, the finds should impact breast cancer research, experts say. "If the spontaneous remission hypothesis is credible, it should cause a major re-evaluation in the approach to breast cancer research and treatment," wrote Robert Kaplan, of the University of California, Los Angeles, and Dr. Franz Porzsolt of the Clinical Economics University of Ulm, Germany, in an editorial that accompanied the journal article. "Certainly, it is worthy of further evaluation."

Right now, however, doctors cannot tell a "bad" breast tumor from a potentially harmless one, so regular mammography screening is still valuable.

"For women, the take-home message remains that mammography done as recommended does decrease the chance of dying from breast cancer across the general population," Mandelblatt said. "Women need to know that there are risks and benefits to all medical interventions, including screening mammography, and the policy recommending mammography is based on the fact that the benefits outweigh some of these harms."

More information

There's more on mammography screening at the U.S. Agency for Healthcare Research and Quality.



SOURCES: Jay Brooks, M.D., chairman of hematology/oncology, Ochsner Health System, Baton Rouge, La.; Jeanne Mandelblatt, M.D., associate director for population sciences, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C; Nov. 24, 2008, Archives of Internal Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Latin Women More Likely to Be Unhappy With Breast Cancer Treatment Decisions
2. First Lady Laura Bushs Partnership for Breast Cancer Awareness and Research Extends to Panama
3. First Lady Laura Bushs Partnership for Breast Cancer Awareness and Research extends to Panama
4. Type of breast reconstruction impacts radiation therapy outcomes
5. Study identifies causes of bone loss in breast cancer survivors
6. Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature
7. Diet, Exercise May Modify Breast Cancer Risks
8. Canola Oil Consumed During Pregnancy Lowers Breast Cancer Risk for Offspring
9. Latinas more likely to regret breast cancer treatment decisions
10. Wealthy More Likely to Have Breast Reconstruction
11. UNC researchers find clue to stopping breast-cancer metastasis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Breast Cancers May Regress on Their Own
(Date:5/23/2016)... Yorba Linda, CA (PRWEB) , ... May 23, 2016 , ... ... the task is so routine. A fresh look at this technique may yield ... enhance the reproducibility of experiments in a cell culture laboratory—and lessen the ...
(Date:5/23/2016)... ... , ... NYDNRehab, a New York City-based physical therapy clinic , is ... this type of technology, which was developed by world-renowned researcher Dr. Christopher Powers of ... , With over 10 million sport injuries per year in the United ...
(Date:5/23/2016)... ... ... ComplianceOnline, the leading governance, risk and compliance advisory network with over 1,000 ... and 16, 2016 in San Diego, CA. The two day summit steered by some ... the largest gatherings of medical device companies, suppliers, professionals and experts in 2016. This ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... today that nominations will be accepted May 23, 2016 through August 5, ... include the Information Security Executive® of the Year, which recognizes executives who ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley Institute for the ... who are blind or visually impaired, announces the election of Julie S. Tye ... Young. Hadley’s Board of Trustees retained Morris & Berger, a firm specializing in ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... -- Gamida Cell, a leader in cellular ... orphan genetic diseases, announced today it has been awarded ... Israel Innovation Authority (formerly the Office of the Chief ... The mission of the Israel Innovation Authority is to ... and technology, while stimulating economic growth. The ...
(Date:5/20/2016)... 20, 2016 ReportsnReports.com adds ... Medical Devices of its online business intelligence library. ... the current state of the Titrator industry. The ... like definitions, classifications, Specifications, applications and industry chain ... like Raw Material Suppliers, Equipment Suppliers, Manufacturing Cost ...
(Date:5/20/2016)... 20, 2016 ReportsnReports.com adds ... 2016" market research report with comprehensive information on ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
Breaking Medicine Technology: